Trials / Completed
CompletedNCT02079597
The Role of Ninjurin-1 During Systemic Inflammation
Prospective Study to Analyze Ninjurin-1 and Its Soluble Part During Systemic Inflammation
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (actual)
- Sponsor
- Dr. Patrick Meybohm, M.D. · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
* With the underlying study the investigators address the question if Ninjurin-1 (Ninj1) expression is altered in patients with systemic inflammatory response syndrome (SIRS) in comparison to healthy volunteers. * The adhesion molecule Ninj1 is induced following nerve injury where it contributes to nerve generation. Besides it is described to facilitate leukocyte migration especially in the nervous system. * The investigators hypothesize that Ninj1 expression is increased in SIRS patients, which will fortify its impact during inflammation and the transferability from bench to bedside.
Conditions
Timeline
- Start date
- 2014-02-01
- Primary completion
- 2014-06-01
- Completion
- 2014-09-01
- First posted
- 2014-03-06
- Last updated
- 2014-09-03
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT02079597. Inclusion in this directory is not an endorsement.